BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27252523)

  • 1. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
    Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
    J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
    Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
    Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
    Knebel B; Haas J; Hartwig S; Jacob S; Köllmer C; Nitzgen U; Muller-Wieland D; Kotzka J
    PLoS One; 2012; 7(2):e31812. PubMed ID: 22363740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
    Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
    J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
    Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
    Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
    Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c.
    Deng X; Zhang W; O-Sullivan I; Williams JB; Dong Q; Park EA; Raghow R; Unterman TG; Elam MB
    J Biol Chem; 2012 Jun; 287(24):20132-43. PubMed ID: 22511764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
    Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
    J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.
    Haas JT; Miao J; Chanda D; Wang Y; Zhao E; Haas ME; Hirschey M; Vaitheesvaran B; Farese RV; Kurland IJ; Graham M; Crooke R; Foufelle F; Biddinger SB
    Cell Metab; 2012 Jun; 15(6):873-84. PubMed ID: 22682225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes.
    Ito M; Nagasawa M; Omae N; Tsunoda M; Ishiyama J; Ide T; Akasaka Y; Murakami K
    J Lipid Res; 2013 Jun; 54(6):1531-1540. PubMed ID: 23515281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver.
    Tian J; Wu J; Chen X; Guo T; Chen ZJ; Goldstein JL; Brown MS
    Elife; 2018 Jun; 7():. PubMed ID: 29952285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex.
    Yellaturu CR; Deng X; Park EA; Raghow R; Elam MB
    J Biol Chem; 2009 Nov; 284(46):31726-34. PubMed ID: 19759400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
    Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner.
    Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P
    FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.